Skip to content
value.today

K Health, Inc.

🇺🇸 New York, New York, USATechnologyFounded 2016
Total raised
$412 M
10 rounds on record
Latest round
$59 M
Jun 2026
First round on record
Nov 2016
Today
Private
No later event on record

Funding rounds

10 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of K Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2026$59 MNo. 10$50 to $250 million

K Health, Inc.: Raise no. 10, Jun 2026

Investors in this round

19 investors had bought by the notice of Aug 19, 2026: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$59 M of $69 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Chen Yehudai · Executive Officer
  • Ran Shaul · Executive Officer
  • Yaron Savoray · Executive Officer
  • Zac Siegel · Executive Officer
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • C. Okey Agba · Director
  • Mark Tluszcz · Director
  • Nir Zohar · Director
  • Niyum Gandhi · Director
  • Saad Ehtisham · Director
  • Vivek Pattipati · Director
  • Vivian Riefberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 19, 2026. Read the notice at the SEC.

equitySEC
Jul 2024$88 MNo. 9$50 to $250 million

K Health, Inc.: Raise no. 9, Jul 2024

Investors in this round

26 investors had bought by the notice of Jul 24, 2024: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$88 M of $134 M offered; $46 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Ashok Balakrishnan · Executive Officer
  • Chen Yehudai · Executive Officer
  • Ran Shaul · Executive Officer
  • Yaron Savoray · Executive Officer
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • Antonio Gracias · Director
  • Hans Tung · Director
  • Mark Tluszcz · Director
  • Vivian Riefberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Yaron Savoray, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 24, 2024. Read the notice at the SEC.

equitySEC
Jan 2021$132 MNo. 8$50 to $250 million

K Health, Inc.: Raise no. 8, Jan 2021

Investors in this round

16 investors had bought by the notice of Jan 19, 2021: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$132 M of $132 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • Antonio Gracias · Director
  • Hans Tung · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jan 19, 2021. Read the notice at the SEC.

equitySEC
Aug 2020$37 MNo. 7$10 to $50 million

K Health, Inc.: Raise no. 7, Aug 2020

Investors in this round

9 investors had bought by the notice of Nov 19, 2020: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Nov 19, 2020. Read the notice at the SEC.

equitySEC
Feb 2020$48 MNo. 6$10 to $50 million

K Health, Inc.: Raise no. 6, Feb 2020

Investors in this round

21 investors had bought by the notice of Mar 5, 2020: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$48 M of $50 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Mar 5, 2020. Read the notice at the SEC.

equitySEC
Jul 2019$12 MNo. 5$10 to $50 million

K Health, Inc.: Raise no. 5, Jul 2019

Investors in this round

1 investor had bought by the notice of Jul 23, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jul 23, 2019. Read the notice at the SEC.

equitySEC
Dec 2018$25 MNo. 4$10 to $50 million

K Health, Inc.: Raise no. 4, Dec 2018

Investors in this round

15 investors had bought by the notice of Dec 19, 2018: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Alejandro Zubillaga · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Dec 19, 2018. Read the notice at the SEC.

equitySEC
Jan 2018$5 MNo. 3$2 to $10 million

K Health, Inc.: Raise no. 3, Jan 2018

Investors in this round

10 investors had bought by the notice of Jan 30, 2018: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jan 30, 2018. Read the notice at the SEC.

equitySEC
Jun 2017$3 MNo. 2$2 to $10 million

K Health, Inc.: Raise no. 2, Jun 2017

Investors in this round

7 investors had bought by the notice of Jun 13, 2017: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jun 13, 2017. Read the notice at the SEC.

equitySEC
Nov 2016$3 MNo. 1$2 to $10 million

K Health, Inc.: Raise no. 1, Nov 2016

Investors in this round

11 investors had bought by the notice of Nov 21, 2016: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allon Bloch · Executive Officer, Director
  • Adam Singolda · Director
  • Mark Tluszcz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Nov 21, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • K Health, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).

    SEC Form D · Aug 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Aug 2026

That is all the official record says: K Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of K Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 10 rounds above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by K Health, Inc.
NameRoleNamed in
Allon BlochExecutive officerAug 2026
Chen YehudaiExecutive officerAug 2026
Ran ShaulExecutive officerAug 2026
Yaron SavorayExecutive officerAug 2026
Zac SiegelExecutive officerAug 2026
Ashok BalakrishnanExecutive officerJul 2024
Adam SingoldaDirectorAug 2026
Alejandro ZubillagaDirectorAug 2026
Allon BlochDirectorAug 2026
C. Okey AgbaDirectorAug 2026
Mark TluszczDirectorAug 2026
Nir ZoharDirectorAug 2026
Niyum GandhiDirectorAug 2026
Saad EhtishamDirectorAug 2026
Vivek PattipatiDirectorAug 2026
Vivian RiefbergDirectorAug 2026
Antonio GraciasDirectorJul 2024
Hans TungDirectorJul 2024